Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Sleep Sciences Announces New Partners

25 Jan 2022 07:00

RNS Number : 5422Z
Barkby Group PLC
25 January 2022
 

25 January 2022

Barkby Group PLC

("Barkby" or the "Company")

Cambridge Sleep Sciences Announces New Partners

Sleep technology business announces multiple new partners as growth continues

Barkby Group PLC (AIM:BARK) is pleased to announce that its subsidiary, Cambridge Sleep Sciences ("CSS"), the science-based sleep technology business behind SleepHub®, has developed more than 10 new sales partnerships as part of its continued growth strategy.

The partnerships, all with leading international businesses, includes retailers Harrods, Smartech (in Selfridges), Currys and Very; sales agents and distributors TKG, Go10, NewGen and Sleep Analysis Australia; and health, wellbeing and fitness brands Lifeworks, Whitecalm and PureGym. CSS's new partnerships will enable them to capitalise on the growing global sleep tech devices market which is forecast to grow at a CAGR of nearly 11% and exceed $30bn by 2028.*

 

These partnerships follow the recent shortlisting of CSS as a finalist in the innovation category of the Medilink Midlands Business Awards for their SleepHub® Home product. CSS also recently announced the development of a portable product - SleepHub® Anywhere, due to be launched this year in Spring.

 

CSS is progressing a number of further major partnerships and looks forward to announcing these shortly.

 

Dr Julian Stone, CEO of CSS, said: "I'm delighted to be partnering with these leading household names as we continue to extend the reach of SleepHub® in our key markets. Collaboration has always been at the heart of our business and we are looking forward to a successful year working with all of our partners to play a role in addressing the global sleep challenge."

 

* Data Bridge Market Research: Global Sleep Tech Devices Market - Industry Trends and Forecast to 2028

 

ENDS

 

Enquiries:

Barkby Group plc

Charles Dickson (Executive Chairman)

Douglas Benzie (CFO)

 

via Camarco

finnCap Ltd (Nomad and Broker)

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

+44 (0) 20 7220 0500

Camarco (Financial PR)

Jennifer Renwick/Jake Thomas

+44 (0) 20 3757 4994

 

Notes to editors

 

About Cambridge Sleep Sciences

 

CSS, part of The Barkby Group Plc, create sleep products which use patented scientifically formulated sound technology to help users achieve quality, natural sleep. Their first product, SleepHub® Home, delivers the unique 'sleep sounds' using a pair of premium speakers. The forthcoming Anywhere product uses the same technology in a compact, portable device, controlled by a mobile app with the sounds delivered through a choice of Bluetooth devices. Other applications of the technology, such as licensing, are in advanced stages and development of their innovation pipeline will remain a focus during this year and beyond.

 

About Barkby Group

 

Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).

 

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASELSMIEESELF
12
Date   Source Headline
30th Jan 20246:03 pmRNSChange of Name to Roadside Real Estate plc
2nd Jan 20247:00 amRNSResult of General Meeting
19th Dec 202311:15 amRNSUpdate on debt refinancing and CSS
15th Dec 20237:00 amRNSFirst joint venture acquisition
13th Dec 20235:39 pmRNSPosting of Circular and Notice of General Meeting
4th Dec 20237:00 amRNSIntention to refinance debt facilities
7th Nov 20237:00 amRNSPractical completion of second Roadside asset
31st Oct 20237:00 amRNSFormation of Roadside Real Estate Joint Venture
29th Sep 20237:00 amRNSTrading update
19th Sep 20237:00 amRNSCSS Announces Licensing Deal with Mammoth
11th Sep 20237:00 amRNSResponse to media speculation re CSS
1st Aug 20237:00 amRNSDisposal of Workshop Coffee
14th Jun 20237:42 amRNSCSS announces new licensing agreement
9th Jun 20237:00 amRNSPub portfolio update
6th Jun 20237:00 amRNSMajor licensing deal for Cambridge Sleep Sciences
31st May 20237:00 amRNSPractical completion of first Roadside asset
15th May 20237:00 amRNSBoard Update, Equity Issue & Total Voting Rights
31st Mar 20237:00 amRNSInterim results
22nd Feb 20235:26 pmRNSResult of AGM
16th Jan 20237:00 amRNSNotice of AGM & Debt Facility Drawing
30th Dec 20227:01 amRNSFinal results for the year ended 2 July 2022
30th Dec 20227:00 amRNSRevised debt facility
28th Nov 20227:00 amRNSTrading and Strategy Update
25th Nov 20227:00 amRNSAcquisition of the Eliot Arms
7th Sep 20225:48 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSTrading and Strategy Update
21st Jun 20223:19 pmRNSDirector/PDMR Shareholding
11th May 20225:21 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSExchange of Contracts at Saffron Walden, Essex
1st Apr 20227:00 amRNSAcquisition of The Coach and Horses
30th Mar 20227:20 amRNSInterim Results
4th Mar 20226:09 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSAppointment of Group Property Director
2nd Mar 20227:00 amRNSVerso Biosense completes clinical study
1st Mar 20227:00 amRNSBoard Update
8th Feb 20225:35 pmRNSResult of AGM
3rd Feb 20223:33 pmRNSIssue of Equity and Total Voting Rights
25th Jan 20227:00 amRNSCambridge Sleep Sciences Announces New Partners
18th Jan 20227:00 amRNSVerso Biosense study nears completion
13th Jan 20227:00 amRNSPosting of Annual Report & Notice of AGM
24th Dec 20217:00 amRNSFinal Results for the Year Ended 1 July 2021
20th Dec 20212:06 pmRNSSecond Price Monitoring Extn
20th Dec 20212:00 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSExchange of Contracts in Swindon, Wiltshire
27th Oct 20214:41 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20212:05 pmRNSSecond Price Monitoring Extn
27th Oct 20212:00 pmRNSPrice Monitoring Extension
27th Oct 202111:05 amRNSSecond Price Monitoring Extn
27th Oct 202111:00 amRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.